U.A.E. and Saudi Arabia Men’s Health Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

U.A.E. and Saudi Arabia Men’s Health Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

  • Medical Devices
  • Feb 2025
  • Country Level
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Uae And Saudi Arabia Mens Health Market

Market Size in USD Million

CAGR :  % Diagram

Bar chart comparing the Uae And Saudi Arabia Mens Health Market size in 2024 - 376.03 and 2032 - 957.98, highlighting the projected market growth. USD 376.03 Million USD 957.98 Million 2024 2032
Diagram Forecast Period
2025 –2032
Diagram Market Size (Base Year)
USD 376.03 Million
Diagram Market Size (Forecast Year)
USD 957.98 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

U.A.E. and Saudi Arabia Men’s Health Market Segmentation, By Type (Treatment and Diagnosis), Disease Type (Male Erectile Dysfunction, Prostate Cancer, Male Hypogonadism and Male Urinary Incontinence), Age Group (Geriatric, Adult and Pediatric), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others) – Industry Trends and Forecast to 2032

Men’s Health Market Analysis

U.A.E. and Saudi Arabia men’s health market is experiencing significant growth, driven by the rising prevalence of lifestyle diseases, increasing incidence rate of infertility in men, and growing investment in healthcare facilities. The market is driven by several factors, including the rising incidence of lifestyle-related diseases such as diabetes, obesity, and cardiovascular conditions among men in the region. Medical devices play a crucial role in this market, with advancements in prosthetics and implants such as penile prostheses (both inflatable and malleable) designed to treat erectile dysfunction and other urological issues. Diagnostic tools and equipment are also integral, facilitating early detection and treatment of men's health conditions such as prostate cancer and male infertility.

Men’s Health Market Size

The U.A.E. and saudi arabia men’s health market size was valued at USD 376.03 million in 2024 and is projected to reach USD 957.98 million by 2032, with a CAGR of 12.40 % during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Men’s Health Market Segmentation        

Attributes

Men’s Health Key Market Insights

Segments Covered

  • By Type: Treatment and Diagnosis
  • By Disease Type:  Male Erectile Dysfunction, Prostate Cancer, Male Hypogonadism and Male Urinary Incontinence
  • By Age Group: Geriatric, Adult and Pediatric
  • By End User: Hospitals, Specialty Clinics, Home Healthcare, and Others

Key Market Players

Cardinal Health, Pfizer Inc., Astellas Pharma Inc., Novo Nordisk A/S, Lilly, Coloplast Corp., AbbVie Inc., Novartis AG, and Boston Scientic Corporation

Market Opportunities

  • Adoption of Telehealth and Digital Solutions

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Men’s Health Market Definition

U.A.E. and Saudi Arabia men's health market is a comprehensive sector focused on addressing the diverse health needs and concerns of men in these regions. This market encompasses a wide range of products, services, and treatments tailored to men's health issues, including but not limited to reproductive health, urological conditions, cardiovascular diseases, and lifestyle-related disorders. Key components of this market include medical devices, pharmaceuticals, healthcare services, and wellness products.

Men’s Health Market Dynamics

Drivers

  • Rising Prevalence of Lifestyle Diseases

The rising prevalence of lifestyle diseases such as diabetes, cardiovascular diseases, and obesity significantly drives the men's health market in the U.A.E. and Saudi Arabia by increasing the demand for healthcare services tailored to men's specific health issues. According to the latest figures from SEHA, men in the U.A.E. are not doing enough to take charge of their health. 70% of Emirati men under the age of 30 years are known to suffer from obesity and diabetes. The wellness and fitness industries are thriving as a result, alongside a rapidly expanding pharmaceutical market catering to these conditions. Evolving healthcare infrastructure, with more clinics and advanced technologies, is rising to meet this demand. Consequently, healthcare providers, pharmaceutical companies, and wellness centers are poised for substantial growth, addressing the significant health challenges in these regions.

  • Increase Incidence Rate of Infertility in Men

The increasing incidence rate of infertility in men acts as a significant driver in the U.A.E. and Saudi Arabia men's health market by boosting the demand for a wide range of medical services and treatments. A cross-sectional sample of patients seeking fertility treatment in a major fertility clinic in Abu Dhabi, U.A.E. was surveyed from April to May 2021 and result shows that out Of the 42 infertile males, 69.0% had an abnormal semen analysis. As infertility becomes a more prevalent concern, this leads to greater utilization of diagnostic services, including semen analysis, hormonal testing, and genetic evaluations, which necessitates the establishment and expansion of specialized fertility clinics and laboratories. The growing need for effective treatment options, such as medication, surgical interventions, and assisted reproductive technologies such as IVF and ICSI, drives investments in advanced reproductive technologies and specialized healthcare providers.

Opportunities

  • Adoption of Telehealth and Digital Solutions

Telehealth and digital solutions are becoming increasingly important in men's health in the U.A.E. and Saudi Arabia. These technologies use advancements in technology to address barriers to access, stigma, and convenience. They enable men to have remote consultations with specialists about sensitive issues such as sexual health and mental well-being from the comfort of their homes. In addition, digital tools allow for continuous monitoring of chronic conditions, personalized wellness plans, and health education, which encourages proactive health management. With supportive regulatory environments and growing acceptance of telemedicine, there is significant potential to enhance healthcare delivery, improve patient outcomes, and promote a culture of preventive care tailored to the specific needs of men in the region.

Restraints/Challenges

  • Cultural and Social Barriers

Societal norms and traditional views on masculinity often discourage men from openly discussing health issues, especially those related to mental health and sexual health. The stigma surrounding these topics is expected to lead reluctance in seeking medical help, resulting in untreated or late-diagnosed conditions. This stigma is further compounded by a lack of awareness and education about men's health, both among the general public and within families. Men may feel pressured to conform to cultural expectations of strength and invulnerability, which can prevent them from adopting preventive healthcare measures or seeking timely treatment.

The increase in healthcare fraud presents a significant obstacle for the Men’s Health market. The prevalence of fraudulent activities undermines trust in Men’s Health solutions, discouraging both users and investors. This creates a barrier to the widespread adoption and growth of Men’s Health technologies. Innovation and investment in Men’s Health initiatives may be hindered as stakeholders become more cautious of the risks associated with fraud, which is restraining the market growth.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Men’s Health Market Scope

The market is segmented on the basis of type, disease type, age group, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Treatment
  • Diagnosis

Disease Type

  • Male Erectile Dysfunction
  • Prostate Cancer
  • Male Hypogonadism
  • Male Urinary Incontinence

Age Group

  • Geriatric
  • Adult
  • Pediatric

End User

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others

Men’s Health Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, disease type, age group, and end user as referenced above.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Men’s Health Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Men’s Health Market Leaders Operating in the Market Are:

  • Cardinal Health
  • Pfizer Inc.
  • Astellas Pharma Inc.
  • Novo Nordisk A/S
  • Lilly
  • Coloplast Corp.
  • AbbVie Inc.
  • Novartis AG
  • Boston Scientific Corporation

Latest Developments in Men’s Health Market

  • In January 2024, Cardinal Health to acquire Specialty Networks and its PPS Analytics platform, a technology enabled multi-specialty group purchasing and practice enhancement organization
  • In June 2023, Cardinal Health announces the merger of its Outcomes business into Transaction Data Systems and related partnership
  • In January 2023, Coloplast appoints new President of its global Interventional Urology business. Mentioned, guiding the IU business into the future, where they will reach an increasing number of clients worldwide with both new and current goods and solutions. They are a growth company with a mission, as well as a fantastic place to work
  • In January 2018, Lilly announced that it has reached a global settlement in numerous federal lawsuits concerning its testosterone replacement therapy drug Axiron, according to federal court records. This resolution will help the company move forward by mitigating legal uncertainties and allowing it to focus on its core business activities and future innovations
  • In November 2023, Boston Scientific recently announced that the U.S. Food and Drug Administration (FDA) has granted approval for its Tenacio pump component, which is a part of the AMS 700 inflatable penile prosthesis (IPP). This approval marks a significant advancement for the AMS 700 IPP, further enhancing its reliability and functionality for patients seeking solutions for erectile dysfunction


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

Some of the major factors driving the market growth are rising prevalence of lifestyle diseases, increase incidence rate of infertility in men, growing investment for healthcare facilities are the major market drivers for the market.
Some of the major market players operating in this market are Cardinal Health (Europe), Pfizer Inc. (U.S.), Astellas Pharma Inc. (Japan), Lilly (U.S.), Coloplast Corp. (Europe), AbbVie Inc. (U.S.), Novartis AG (Switzerland), and Boston Scientific Corporation (U.S.) among others.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Industry Related Reports

Testimonial